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AbstrACt
background Cardiovascular disease poses a great 
financial risk on households in countries without universal 
health coverage like Ethiopia. This paper aims to estimate 
the magnitude and intensity of catastrophic health 
expenditure and factors associated with catastrophic 
health expenditure for prevention and treatment of 
cardiovascular disease in general and specialised cardiac 
hospitals in Addis Ababa.
Methods and findings We conducted a cross-sectional 
cohort study among individuals who sought cardiovascular 
disease care in selected hospitals in Addis Ababa during 
February to March 2015 (n=589, response rate 94%). 
Out-of-pocket payments on direct medical costs and 
direct non-medical costs were accounted for. Descriptive 
statistics was used to estimate the magnitude and 
intensity of catastrophic health expenditure within 
households, while logistic regression models were used 
to assess the factors associated with it. About 27% (26 
.7;95% CI 23.1 to 30.6) of the households experienced 
catastrophic health expenditure, defined as annual out-
of-pocket payments above 10% of a household’s annual 
income. Family support was the the most common 
coping mechanism. Low income, residence outside Addis 
Ababa and hospitalisation increased the likelihood of 
experiencing catastrophic health expenditure. The bottom 
income quintile was about 60 times more likely to suffer 
catastrophic health expenditure compared with the top 
quintile (adjusted OR=58.6 (16.5–208.0), p value=0.00). 
Of those that experienced catastrophic health expenditure, 
the poorest and richest quintiles spent on average 34% 
and 15% of households’ annual income, respectively. Drug 
costs constitute about 50% of the outpatient care cost.
Conclusions Seeking prevention and treatment 
services for cardiovascular disease in Addis Ababa poses 
substantial financial burden on households, affecting the 
poorest and those who reside outside Addis Ababa more. 
Economic and geographical inequalities should also be 
considered when setting priorities for expanding coverage 
of these services. Expanded coverage has to go hand-in-
hand with implementation of sound prepayment and risk 
pooling arrangements to ensure financial risk protection to 
the most needy.
IntroduCtIon
Universal health coverage (UHC) calls for 
ensuring that all people receive quality health 
Key questions
What is already known about this topic?
 ► Out-of-pocket payments for healthcare impose 
catastrophic financial burden on households 
especially affecting those with chronic conditions 
such as cardiovascular disease.
 ► In Ethiopia, out-of-pocket payments constitute about 
one-third of the total health spending.
 ► No evidence exists on the magnitude of financial 
burden related to accessing cardiovascular disease 
care in Addis Ababa, Ethiopia.
What are the new findings?
 ► Seeking care for cardiovascular disease presents 
substantial financial burden on households in Addis 
Ababa, Ethiopia.
 ► Poorer households face a multifold higher financial 
risk compared with the richer.
 ► Hospitalisation and seeking care in private facilities 
were among the factors that increased the likelihood 
of catastrophic health expenditure.
 ► Households largely depended on support from family 
members to cope with high out-of-pocket payments.
recommendations for policy
 ► Drug costs constitute about half of out-of-pocket 
payments. This might encourage practitioners to 
increasingly prescribe generic drugs.
 ► Additionally, findings could inform the design of 
benefit packages for health insurance mechanisms.
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services they need without exposing them to financial 
hardship.1–3 Countries that overly rely on out-of-pocket 
(OOP) payments to finance their health system pose a 
huge financial burden on households,4 forcing them 
to receive healthcare at the expense of other essential 
needs  such as food and education.1 In addition, OOP 
payments at the point of service delivery may force house-
holds to delay or abandon some or all health services 
that people need.2 5
Major sources of financial burden include spending on 
direct medical costs (eg, consultation fees, drugs, labora-
tory and hospital bed days), direct non-medical costs (eg, 
transportation) and indirect costs (eg, lost income due 
to lost productivity by patients and their attendants).5 6 
Households resort to various coping strategies to ensure 
other essential needs in the face of high OOP payments. 
Commonly used mechanisms include use of personal 
savings, borrowing, seeking support from family or 
friends and asset sale.5 7 8 At times, household members 
may be forced to adjust work schedule, downgrade living 
conditions and disrupt children’s schooling.5–12 Low 
socioeconomic status, rural residence, not having health 
insurance, long inpatient days and having a chronic 
disease were associated with increased risk of catastrophic 
health expenditure (CHE) in Asia and Africa.4 6 11 13
Globally, millions bear catastrophic financial 
burden due to OOP payments related to seeking 
healthcare.3 14 Patients with chronic diseases such as 
cardiovascular disease (CVD) face higher financial 
risk due to the need for long-term treatment and care, 
loss of productivity as a result of long-term illness and 
disability, and high costs when acute episodes occur.15–18 
In a large study from India, households with a member 
suffering from CVD spent 17% more of the total 
households' expenditure for healthcare compared to 
households without CVD.6 High rates of CHE related to 
CVD have also been reported in various low-income and 
middle-income countries. Among patients with a recent 
history (15 months) of hospitalisation for CVD, 80% in 
Tanzania, 55% in China13 19 and up to 84% in India11 13 
experienced CHE. In another study from seven Asian 
countries, 66% of patients with a history of admission for 
acute coronary syndrome experienced CHE.20
Addis Ababa, being the capital city and a home to 
about a quarter of the urban population in Ethiopia, is 
heavily affected by CVD and its risk factors.21–25 During 
the period 2002–2010, CVD was among the leading 
causes of mortality accounted for 11%–24% of all deaths 
in Addis Ababa.22 23 A significant reduction in financial 
burden related to CVD care could be attained through 
scale-up of cost-effective prevention and treatment strate-
gies26–28 through prepayment financing arrangements.1 5 
However, coverage of such interventions is low in Addis 
Ababa.21 29 The Ethiopian health system is severely 
underfinanced (US$27 per capita in 2015) and highly 
dependent on OOP payments by households.30 31 The 
coverage of health insurance is very low (about 1% in 
2012), although plans are underway for expansion.32 As a 
result, 59% and 88% of those who sought outpatient and 
inpatient care covered cost of care fully through OOP 
payments, respectively.32
In 2005, the government identified a prioritised list of 
basic Essential Health Services Package (EHSP) that the 
country can afford to offer its citizens at public primary 
care settings.33 The EHSP offers only a basic package 
of services free of charge to all, such as immunisation, 
child delivery and tuberculosis/HIV treatment . Except 
for treatment of hypertension, which is subsidised, 
CVD care is largely offered on the basis of high (full) 
cost recovery, even in public facilities that households 
pay on use of services.33 With the aim of protecting the 
poorest households from financial risk related to seeking 
healthcare, the fee-waiver scheme reached out to nearly 
1.5 million people (1.5% of the Ethiopian population) 
with free healthcare access at an average spending of 
less than US$2 per capita in 2015/2016.34 In addition to 
its suboptimal coverage, less effective targeting further 
compromises the effectiveness of the scheme.32
According to the World Health Survey (2003), 27% 
of households in Ethiopia faced financial catastrophe—
defined as OOP payments of more than 10% of 
household’s consumption expenditure.35 36 Little is 
known about CVD-related CHE in Ethiopia. Given the 
high and increasing burden of CVD and its risk factors 
in Addis Ababa21–24 and the fact that OOP payments by 
households contribute to about 34% of the total health 
expenditure in Ethiopia,32 it is crucial to document the 
magnitude of financial burden households face related 
to seeking prevention and treatment services for CVD in 
Addis Ababa. Lack of such information has been iden-
tified as one of the gaps that needs to be addressed for 
better monitoring of the progress towards UHC in Ethi-
opia.37
The objective of this paper is to estimate the magnitude 
and intensity of CHE and factors associated with CHE for 
prevention and treatment of CVD in general and special-
ised cardiac hospitals in Addis Ababa.
MAterIAls And Methods
study design and population
We conducted a cross-sectional cohort study among indi-
viduals who sought prevention and treatment care for 
CVD in a sample of general and specialised cardiac hospi-
tals in Addis Ababa, Ethiopia. All adults with a diagnosis 
of ischaemic heart disease (IHD), stroke, hypertension 
and dyslipidaemia were included in the study. Newly diag-
nosed patients who were on their first outpatient visit 
were excluded.
study site and sample selection
We estimated a sample size of 625, assuming 27% CHE 
among the richest quartile (Q4),35 36 15% point differ-
ence with the poorest (Q1) and 1.5% non-response rate 
using the formula38:
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n = (Zα/2+Zβ) 2 * (p1 (1-p1)+p2 (1-p2)) / (p1-p2)2, 
where n is the sample size required in each quartile, p1 
and p2 are the expected sample proportions of any two 
quartiles, Zα/2 is the critical value of the normal distri-
bution at α/2 for a confidence level of 95%, α is 0.05, Z is 
1.96, Zβ is the critical value of the normal distribution at 
β for a power of 80%, β is 0.2 and the critical value is 0.84.
There were 11 public and 38 private hospitals in Addis 
Ababa at the time of the data collection, including one 
public and three private specialised cardiac hospitals.39 
In general, public facilities are major providers of outpa-
tient and inpatient care in urban settings in Ethiopia.32 We 
anticipated public and private facilities to have an equal 
role in the provision of CVD care, given the large number 
of private facilities in Addis Ababa. Therefore, we used a 
purposive sampling technique to select eight hospitals—
in consultation with experts—where individuals having 
the diagnoses of interest were expected to concentrate. 
Four specialised cardiac hospitals (one public and three 
private) and four general hospitals (three public and one 
private) were selected.
To ensure representativeness at a hospital level, we 
used a stratified sampling technique and distributed the 
sample quota equally between public and private facilities 
overall and allocated 70% of the sample for the special-
ised cardiac centres taking one-third of this share from 
the only public cardiac centre. To adjust for this sampling 
variation, each observation was weighted according to 
the inverse of its probability of being selected.
In each hospital, all eligible individuals were sequen-
tially recruited from cardiac or chronic disease outpatient 
follow-up clinics and inpatient wards by hospital nurses 
based on the diagnosis on respective medical charts until 
the sample quota for that particular facility was met.
data collection
The data collection period ran from February to March 
2015 with a range of 4–8 weeks, depending on the time 
needed to recruit the allocated sample quota in specific 
hospitals. Data were collected through face-to-face 
interviews by trained enumerators using a structured 
questionnaire (see online supplementary annex 1). The 
questionnaire was developed building on an instrument 
used in a study on ‘microeconomic impact of CVD hospi-
talisation in four low- and middle-income countries’ 
including Tanzania.13 The questionnaire was prepared 
in English and then translated to Amharic (national 
language) for ease of administration and then back trans-
lated to English to ensure consistency. It was pilot-tested 
in one public hospital and one private hospital in Addis 
Ababa prior to the actual data collection. Strong data 
quality assurance measures were employed including, 
random on-site visits during the interviews, random 
verification checks using hospital records, and random 
phone calls to patients for data validation.
Outpatients were interviewed on exit from the 
follow-up visits, while interviews with inpatients were 
completed on discharge from the hospitals so as to fully 
capture the expenditures during the data collection 
period. The interviews were conducted in nurses’ rooms 
or other dedicated rooms and were to a large extent 
(82%) informed by the care-seekers themselves, followed 
by accompanying relatives attending to 15% of the inter-
views. On average, respondents took 24 min to complete 
the interviews with a range of 14–52 min and SD of 7 min.
Among others, data on participants’ sociodemographic 
characteristics, medical history, households’ income and 
OOP payments for outpatient and inpatient care and 
the number of outpatient follow-up visits were collected. 
Households’ income was defined as the average reported 
monthly earnings of all economically active house-
hold members' net of tax through formal employment, 
self-employment, in exchange of goods or services as well 
as cash transfers from any sources including family and 
friends. OOP payments constitute fees for consultations, 
drugs, laboratory tests, imaging and hospital bed days as 
well as direct non-medical expenses on transportation, 
accommodation and food for patients and accompanying 
caregivers. We found no report of informal payments 
to service providers. We also collected information on 
sources of financing that households used to cope with 
OOP payments.
For each individual, OOP payments for CVD care was 
estimated over a 12-month reference period retrospec-
tively from the day of data collection. Outpatient care 
expenditures were reported at two data points: for outpa-
tient care received at the day of data collection and for 
the outpatient visit prior to the day of data collection. 
The time elapsed between these two visits ranged from 
1 to 6 months for 95% of the participants with a range 
of 2 weeks to 12 months. Whereas, inpatient care expen-
ditures were reported separately for each hospitalisation 
over the same reference period. OOP payments and 
income data were measured in Ethiopian birr (ETB) 
and then converted to 2015 US$ using the prevailing 
official exchange rate for the study period (1 US$ = 
ETB 20.33).40 An exchange rate of 4.92 ETB per unit $ 
purchasing power parity (PPP)) in 2011 was used for the 
poverty analysis.30
Six hundred and twenty-five individuals were recruited 
for the study. Of them, five refused to participate and 31 
were excluded due to missing data on OOP payments 
and or household’s income, as these participants did 
not report such data or inconsistent diagnosis with the 
inclusion criteria. In the end, 589 were included in the 
final analysis, making the response rate 94%. Of these 
589, 69% (n=406) and 52% (306) were recruited from 
specialised centres and from public facilities, respectively. 
Whereas 94% (n=553) were recruited from outpatient 
units, 6% (n=36) were hospitalised on emergency basis at 
the time of the survey, 65% of which in private facilities.
The subjects that were excluded due to poor data 
quality were fairly comparable with the remaining study 
subjects with respect to place of residence and gender. 
However, excluded subjects tend to be younger and more 
in the private hospitals (data not shown). The potential 
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impact of this exclusion on our results is minimal given 
their small number.
Analysis
Data were cleaned and processed using Stata V.14. 
Households were used as the unit of analysis. As CVD is a 
chronic condition, estimation of annual OOP payments 
was needed to allow a reasonable assessment of the finan-
cial burden on households. Accordingly, annual OOP 
payments were estimated as the sum of annual OOP 
payments for outpatient care and annual OOP payments 
for inpatient care for those who received inpatient care. 
Annual outpatient care expenditures were estimated as 
a product of the mean OOP payments per outpatient 
visit and the number of outpatient follow-up visits over 
the 12-month period. Mean OOP payments per visit, 
in turn, were estimated from OOP payments for outpa-
tient care received at the day of data collection and the 
outpatient follow-up visit prior to that date. For individ-
uals that received inpatient care, annual inpatient care 
expenditures were derived as the sum of OOP payments 
for each hospitalisation over the same reference period. 
Although only 6% of the study participants were hospital-
ised at the time of the survey, another 11% had received 
inpatient care historically.A smaller proportion (2% of all 
subjects) that had two hospitalisations. Accordingly, all 
these expenditures were taken into account in estimating 
annual OOP payments. On a related note, only OOP 
payments directly related to prevention and treatment of 
CVD were included in our analysis. Nearly 10% of study 
participants had diabetes as comorbidity. However, partic-
ipants were asked to exclusively report on OOP payments 
pertaining to CVD care and hence only such reported 
expenditures were included in the analysis.
Descriptive statistics was used to quantify the magni-
tude and intensity of CHE based on previously published 
methods (details are provided in online supplementary 
annex 2.1).5 41 We used a 10% threshold to define CHE: 
a given household is said to have experienced CHE when 
the estimated annual OOP payments exceed 10% of the 
household’s annual income. The magnitude of CHE is 
then given by the proportion of households that experi-
enced CHE. Households used various means other than 
current income to cover OOP payments. We therefore 
explored the impact of using these coping mechanisms 
on CHE by deducting OOP payments financed through 
such means from the total OOP payments as recom-
mended by Leive and others7 9 and presented respective 
results for comparison. To assess the intensity of CHE 
among households that faced CHE, we estimated the 
average amount by which such households exceeded the 
10% income threshold. This is known as mean positive 
overshoot, and it is expressed in percentage relative to 
household's’ income over the given CHE threshold.5 41 
In order to assess the distribution and intensity of CHE 
across income quintiles, households were divided into 
quintiles based on households’ income and were desig-
nated as Q1 (the poorest) to Q5 (the richest). We used 
t-test to assess the significance of the differences in the 
magnitude of CHE across income groups. Given the 
nature of the study population (secondary and tertiary 
hospital-level study in the capital), the income level of 
households in our study is higher compared with the 
national figure.30 Only 11% of households in our study 
were below the poverty line of $1.9 per day (in 2011 PPP) 
compared with 33% for the whole country in 2011 and 
36% for Addis Ababa in 2000.30 42
Logistic regression models were used to examine 
factors associated with CHE. Potential covariates were 
chosen mainly guided by existing literature and scien-
tific relevance7 13 18 and include income level, residence, 
type of hospital, hospitalisation for CVD over the past 
12 months, having developed a CVD event (stroke or 
IHD), age of patient, time elapsed since diagnosed, 
occupation and household size. Each covariate was first 
assessed in bivariate models, followed by a multivariate 
analysis controlling for all covariates that were signifi-
cantly associated with CHE at p value of less than or equal 
to 0.1 in bivariate models taking Q5 (the richest) as the 
reference group. p -Values of less than or equal to 0.05 
and 95% CIs were used as cut-off points to classify respec-
tive ORs as statistically significant.
ethical considerations
The research protocol was reviewed and approved by the 
Scientific Ethical Review Committee of the Ethiopian 
Public Health Institute (005-02-2015/EPHI 6.13/65) and 
exempted by the Norwegian Regional Research Ethics 
Committee. We acquired written informed consent from 
the study participants before administering the question-
naire. The consent form was translated to Amharic (local 
language) before use.
sociodemographic characteristics of study participants
With a mean age of 58 years, about half (48%) of the study 
subjects were engaged in an economically productive job 
at the time of data collection. One-in-five resides outside 
of Addis Ababa (table 1), with an average distance of 
254 km (range: 10–1000 km) from the respective hospi-
tals (data not shown).
Fifty-four per cent of the participants had developed a 
CVD event (IHD and stroke), and the rest were still on 
primary prevention. Although only 6% of the participants 
were hospitalised during the data collection period, 17% 
in total have received inpatient care for CVD during the 
12-month reference period (table 1).
results
Magnitude of catastrophic household ooP payments
The magnitude and distribution of CHE across income 
quintiles is presented in table 2. Overall, about 27% of 
the households experienced CHE. Regarding the distribu-
tion of CHE, 28% was among the poorest quintile (Q1) 
compared with 14% among the richest quintile (Q5) 
(table 2). p Value from t-test comparing the two proportions 
was found to be 0.02, indicating a statistically significant 
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higher magnitude of CHE among the poorest households. 
However, the increase in the magnitude of CHE across 
income quintiles was not monotonic. The magnitude of 
CHE dropped to about 8% when OOP payments financed 
through sources other than households’ current income 
were deducted from the total OOP payments. Absolute 
amount of OOP payments across quintiles is presented in 
figure 1, showing steady increase in the mean annual OOP 
payments with increasing income level. Further details 
regarding absolute OOP payments are provided in table 
A.2.2.1 in online supplementary annex 2. Here we focus 
on relative measure of financial burden—CHE.
Factors explaining catastrophic ooP payments
Results from multiple logistic regression model are shown 
in table 3. After adjustment for available covariates, the 
odds of facing CHE among hospitalised subjects was 
about eight times that of the non-hospitalised subjects 
(OR=8.39, 95% CI (4.24, 16.59) p value<0.001). Seeking 
care in private hospitals increased the odds of CHE by 
20 fold (OR=20.7, 95% CI (10.2, 42.04) p value<0.001) 
compared with public hospitals. Moreover, travelling to 
Addis Ababa for CVD care and having developed stroke 
substantially increased the likelihood of facing CHE. In 
contrast, the odds of facing CHE went down the longer 
the duration since diagnosed (table 3). Age and occupa-
tion were not significantly associated with CHE.
Income level was strongly negatively associated with 
CHE. The odds of facing CHE among the poorest quin-
tile was about 60 times that of the richest (OR=58.62, 
95% CI (16.2, 208.0) p value<0.00). ORs increase steadily 
going down the income strata (table 3).
Intensity of catastrophic ooP payment
Households in lower economic strata experienced 
higher magnitude of CHE and suffered a more intense 
degree of CHE. The share of OOP payments relative to 
households’ income increased as we go down income 
strata. Among households that faced CHE, the bottom 
two quintiles overshoot the CHE threshold on average 
by 24% of households’ income compared with an over-
shoot of only 5% for the richest quintile (table 4). In 
other words, households that experienced CHE in Q1 
spent 34% of households’ income on average for CVD 
care compared with a share of 15% among those in Q5. 
This indicates a more intense financial risk among the 
economically disadvantaged groups.
Cost items
About 80% (n=475) of the participants were able to report 
outpatient care expenditures disaggregated by cost items. 
Accordingly, direct medical costs constitute 65%–83% of 
OOP payments, while direct non-medical costs, mainly 
transport, contribute to 16%–34% of outpatient care 
cost. Drug costs were the major cost drivers comprising 
about 50% of outpatient care costs (figure 2). Disaggre-
gating inpatient care expenditures was challenging to 
respondents and hence data are not presented.
sources of financing
Households resort to various coping mechanisms to deal 
with high OOP payments for CVD care. The commonly 
used coping strategies other than current income were 
support from family members and savings (table 5). 
Dependence on coping strategies was more pronounced 
for inpatient care compared with outpatient care. We 
found that 39% fully financed inpatient care through 
support from family members compared with 27% for 
outpatient care. A percentage of 11–27 tapped into their 
savings and another 2%–8% had to borrow to cover part 
or all of outpatient and inpatient care costs (table 5). 
Table 1 Sociodemographic characteristics
Characteristics n=589 %




Gender Female 298 51
Male 291 49




Residence Addis Ababa 470 80
Outside Addis Ababa 119 20
Education No formal education 115 20
Grade 8 or less 163 28
Grade 9–12 146 25
Diploma 85 14
Bachelor degree+ 80 13
Occupation Government employee 119 20
Private employee 38 6
Private business 109 19
Stay home mum 162 28
Retired 135 23
Other 26 4
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dIsCussIon
This is the first study to quantify the magnitude and 
intensity of CHE related to seeking CVD care in Ethi-
opia. Our analysis revealed seeking CVD care at hospitals 
in Addis Ababa exposes households to substantial finan-
cial risk, with about 27% of those that do so face CHE. 
Low economic status, residence outside Addis Ababa, 
hospitalisation and seeking care in private hospitals were 
among factors that increased likelihood of CHE. Poorest 
households suffered greater intensity of CHE compared 
with the richest. The magnitude of CHE in our study 
was lower than what others reported in various low-in-
come and middle-income settings,6 11 13 18 although direct 
comparison is not straightforward due to differences in 
study populations and criteria for CHE. For example, 
Huffman et al reported CHE that ranges from 55% in 
China to 80% in Tanzania.13 Nevertheless, 27% is still 
much higher than what Memirie et al reported (about 
11%) among households that sought inpatient care for 
severe pneumonia and diarrhoea among children under 
5 years in Ethiopia.43
Several factors could have contributed to the seem-
ingly lower magnitude of CHE in Addis Ababa. First, 
poorest households that are more prone to CHE were 
under-represented in our study resulting in possible 
underestimation of CHE. This is because direct OOP 
payments at the point of care are well-established barriers 
to access healthcare, disproportionately affecting poorer 
households.1 32 This could have been further exacerbated 
by a low utilisation of CVD care in Ethiopia (approxi-
mately 12% according to the latest STEPwise approach 
to NCD risk factor surveillance (STEPS))24 29 44 and the 
fact that hospitals are more accessible to richer people 
compared with poorer.36 42 45 This is one of the limitations 
of hospital-based cross-sectional cohort study designs, 
warranting cautious interpretation of our results. Due 
to the deceptive nature of parameters such as CHE, the 
WHO and World Bank recommended their use along 
with coverage indicators to get a fuller picture.46
However, differences in composition of study subjects 
could also offer a partial explanation. Only 14% of our 
study participants were hospitalised for an acute CVD 
event, while 46% were still on primary prevention whereas 
the other studies were largely based on data from recently 
hospitalised patients for acute CVD events that are cost-
lier (eg, percutaneous coronary intervention) than basic 
pharmaceutical prevention and treatment packages avail-
able in Ethiopia.11 13 47 Still, on a subgroup analysis of our 
data, we found higher CHE especially among those that 
developed stroke (close to 50%). We did not present 
those results as our study was not powered to allow 
detailed analysis by specific diagnostic categories.
CHE was shown to be inversely related with income 
level. Nevertheless, the increase in magnitude was not 
monotonic going down income strata (table 3). This is 
possibly due to suboptimal utilisation of needed services 
among the poorest, for example, skipping some of 
prescribed drugs or tests due to inability to pay, though 
we do not have data to validate this. Consequently, 
Table 2 Proportion of households that faced catastrophic out-of-pocket (OOP) payments for prevention and treatment of 
cardiovascular disease in general and specialised cardiac hospitals in Addis Ababa, Ethiopia, 2015.
Without adjustment Adjusted*
Proportion (%) SE† 95% CI‡ Proportion (%) SE† 95% CI‡
Total 26.7 1.9 23.1 to 30.6 7.9 1.2 5.8 to 10.5
Q1 27.9 4.4 20.0 to 37.3 8.0 2.7 4.1 to 15.1
Q2 28.5 3.8 21.7 to 36.6 7.1 2.2 3.8 to 13.0
Q3 32.2 5.0 23.3 to 42.6 9.3 3.1 4.7 to 17.3
Q4 28.3 4.1 21.0 to 37.0 7.7 2.4 4.1 to 14.0
Q5 13.9 3.8 7.9 to 23.1 7.7 3.0 3.5 to 15.9
*The amount of OOP payments financed through means other than current income is deducted from the total OOP payment, p value 
comparing proportion without adjustment among Q1 an Q5 =0.015.
SE is standard error of the mean.
‡95% CI for the proportion.
Figure 1 Annual out-of-pocket payments across income 
quintile for prevention and treatment of cardiovascular 
disease in general and specialised cardiac hospitals in 
Addis Ababa, Ethiopia in 2015 US$.
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poorest households might have incurred lower expendi-
tures resulting in a relatively lower magnitude of CHE. 
Although with wide 95% CI due to smaller sample (169 
developed CHE), results from multiple logistic regression 
models also confirmed this linear inverse relationship 
consistent with Huffman et al’s finding in Tanzania.13 As 
Table 3 Logistic regression analysis of factors associated with catastrophic out-of-pocket payments for prevention and 
treatment of cardiovascular diseases in general and specialised cardiac hospitals in Addis Ababa, Ethiopia, 2015
Covariates OR 95% CI p Value
Income quintiles Q1 58.6 16.52 to 208.0 0.00
Q2 39.0 11.87 to 128.24 0.00
Q3 20.9 6.97 to 62.92 0.00
Q4 6.9 2.4 to 19.99 0.00
Q5 1
Residence Addis Ababa 1
Outside Addis Ababa 3.25 1.79 to 5.90 0.00
Type of hospital visited Public 1
Private 20.71 10.21 to 42.05 0.00
Received inpatient care for CVD over 
the past 12 months
No 1
Yes 8.39 4.24 to 16.59 0.00
Diagnosis* IHD 1.15 0.65 to 2.06 0.63
Stroke 4.10 1.82 to 9.18 0.01
Hypertension or Dyslipidaemia 1
Household size Household size 1.20 1.06 to 1.36 0.04
Age of participants Patient’s age 1.00 0.98 to 1.02 0.02
Duration since diagnosed Duration since diagnosed 0.99 0.98 to 0.99 0.05
Occupation of participants Employed† 1.07 0.44 to 2.58 0.88
Private business 0.91 0.38 to 2.17 0.84
Housewife/househusband 1.34 0.67 to 2.65 0.41
Retired 1
Others 1.23 0.36 to 4.14 0.73
*IHD stands for ischaemic heart disease, Q1 for poorest quintile and Q5 stands for richest quintile. †Includes government and private 
employees.
CVD, cardiovascular disease.
Table 4 Intensity of catastrophic out-of-pocket payments for prevention and treatment of cardiovascular disease across 
income group in general and specialised cardiac hospitals in Addis Ababa, Ethiopia, 2015.
Income group
Mean positive overshoot over the 10% income threshold (%)
 Baseline Adjusted*
Mean† SE‡ 95% CI§ Mean SE‡ 95% CI§
Total 17.6 2.2 13.1 to 22.1 12.9 3.3 6.3 to 19.5
Q1 23.6 5.2 13.4 to 33.9 14.5 5.9 2.6 to 26.4
Q2 23.9 6.7 10.6 to 37.1 25.2 11.8 1.5 to 48.9
Q3 14.0 2.6 8.8 to 19.2 9.3 3.0 3.3 to 15.3
Q4 12.9 2.4 8.2 to 17.6 9.3 3.8 1.7 to 16.9
Q5 4.8 1.2 2.4 to 7.1 3.0 1.0 0.9 to 5.1
*Amount of OOP payments financed through means other than current income is deducted from the total OOP payment. 
†The average amount by which households that experienced catastrophic OOP payments within the total population, Q1, Q2, Q3, Q4 and 
Q5 exceeded the 10% household income threshold expressed as in % as a share of household income.
‡SE of the mean.
§95% CI for the mean.
OOP, out-of-pocket.
group.bmj.com on March 6, 2018 - Published by http://gh.bmj.com/Downloaded from 
8 Tolla MT, et al. BMJ Glob Health 2017;2:e000280. doi:10.1136/bmjgh-2016-000280
BMJ Global Health
might be expected, hospitalisation, patients who travel to 
Addis Ababa to receive CVD care and those who visited 
private settings experienced greater financial risk. This 
is due to the additional cost related to travel and higher 
prices of services in private settings. The significance of 
direct non-medical costs to CHE have also been identi-
fied by others.41
It is, however, worrisome that the poorest households 
who by large sought care in public hospitals (more than 
80% of bottom 40%, Table A.2.2.2 in online supplemen-
tary annex 2) where services are offered at subsidised rate 
suffered a greater financial risk even after controlling 
relevant covariates.48 This is possibly indicative of subop-
timal implementation of ongoing healthcare financing 
reforms.49 For example, even though drugs could have 
been purchased at a subsidised price in public facilities, 
promised benefits may not be realised unless sustained 
availability and use of generic drugs is ensured.50 We 
found drug costs to be major drivers in outpatient care 
costs—a finding also reported elsewhere.6 42 Therefore, 
ensuring effective implementation of ongoing reforms 
would be vital to attain the desired financial risk protec-
tion benefits. Conversely, poorest households’ limited 
capacity to cope with an even small amount of OOP 
payments could also partly explain the greater financial 
risk among this subgroup.5
The magnitude of CHE dropped remarkably on adjust-
ment of OOP payments covered through sources of 
financing other than households’ current income. Reli-
ance on such coping mechanisms was higher among the 
poorest households as is the case elsewhere.7 8 13 Though 
this might signal that households were able to tempo-
rarily cope with high OOP demand, it largely came at the 
expense of support from family members. The long-term 
impact of such expenditures on economic situation of 
the supporting families is questionable and worth further 
investigation.9
Now that the health infrastructure and human 
resource situation have greatly improved in Ethiopia,51 
expansion of health insurance and health services is a 
natural next step that could address part of the problem. 
Effective mechanisms need to be put in place to confine 
the unwanted financial consequences seeking CVD care 
for affected households and their families. To this end, 
the Ethiopian national health policy (draft, 2015/2016) 
identified financial risk protection as one of its main 
goals.52 Accordingly, the draft national Health Care 
Financing strategy (2015–2035) proposed four reforms: 
(A) scale-up of community based health insurance for 
those in the informal sector (about 89% of the popula-
tion), (B) launching of social health insurance for formal 
sector employees, (C) expanding the fee waiver system to 
the poorest households and (D) maintaining the general 
subsidy at public health facilities.49 53–55
Our results should be interpreted with caution in view 
of the study limitations. The study does not capture 
the prohibitive impact of OOP payments on utilisation 
of CVD care. Not capturing non-use and underutilisa-
tion of health services due to financial barriers is one 
of the major limitations of facility-based cross-sectional 
cohort studies—a limitation that has also been previ-
ously identified.56 Another limitation is that we relied 
on self-reported data on OOP payments and household 
income with significant risk of reporting error.
Given the 12-month reference period used to measure 
OOP payments, respondents might not remember all 
expenditures correctly. To a large extent, this could 
have resulted in an under-reporting of OOP payments 
although one cannot rule out the possibility of over-re-
porting.57
In contrast, though shorter recall periods may help 
in minimising memory loss, one might fail to capture 
possible non-uniform expenditure patterns evident over 
longer time span.57 Therefore, it is important to find 
the right balance between the appropriate recall period 
and risk of recall problem especially for chronic condi-
tions such as CVD. Related to this, OOP payments were 
Figure 2 Contribution of cost items as a share of total 
outpatient expenditure for prevention and treatment 
of cardiovascular disease in general and specialised 
cardiac hospitals in Addis Ababa, Ethiopia, 2015.
Table 5 Proportion of out-of-pocket payments financed 
through various sources by type of care for prevention 
and treatment of cardiovascular disease in general and 
specialized cardiac hospitals in Addis Ababa, Ethiopia.
Sources of finance Proportion*
Type of care
Outpatient Inpatient
  Current income None 36.7 71.0
100% 48.0 20.0
  Saving None 89.1 73.0
100% 5.6 14.0
  Family support None 59.7 45.0
100% 27.1 39.0
  Borrowing None 98.6 92.0
100% 0.4 5.0
  Asset sale None 99.3 97.0
100% 0.2 2.0
  Insurance None 90.5 98.0
100% 0.2 0
*Proportion of out-of-pocket payment financed from each source.
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captured with a detailed breakdown of cost–items such as 
drugs, bed days and so on. Though these could be cited 
among the strengths of our study,57 58 it was not always easy 
for respondents to provide all the details. In the future, 
alternative ways of real-time data collection mechanisms, 
for example, prospective mobile phone-based data collec-
tion systems could be explored. Additionally, we did not 
capture OOP payments for traditional treatment of CVD, 
if any. However, OOP payments to traditional providers 
constituted only to 2% of household OOP expenditures 
in Ethiopia in 2012.32
Although consumption expenditures are preferred 
measures of living standards especially in low-income 
settings, we used reported income. Nearly half of 
the study participants were in the formal sector and 
were men. Therefore, reporting income was relatively 
easier for them compared with consumption expendi-
tures. However, we did not account for possible in-kind 
transfers to households. Given that Addis Ababa is a large 
urban centre, we do not anticipate this to introduce 
major bias. Moreover, as our main focus was assessing the 
impact of OOP payments, we did not include lost income 
in our analysis, but we have provided results on time lost 
in Table A.2.2.3 in online supplementary annex 2.
Though primary prevention services for CVD are 
available at health centres and clinics, the service provi-
sion for chronic conditions is not so organised in those 
settings making data collection a bit more challenging. 
Therefore, we excluded those facilities from our sample. 
In view of this, generalisability of our findings beyond 
hospital settings is deemed limited.
Moreover, although households were used as the unit 
of analysis in our study, we did not collect data regarding 
possible OOP payments on CVD care for household 
member(s) other than the primary participants. Though 
relevant, we do not anticipate this to have a major impact 
on the final results given the low prevalence of family 
history of CVD in our study (4.8% reported having a 
first degree relative with a history of CVD). Additionally, 
even though we have explored a number of potential 
predictors of CHE available in our data, problems of 
endogeneity and identification are always an issue when 
fitting logistic regression to cross-sectional cohort data. 
Our model might therefore be lacking other unob-
served covariates relevant to the independent variables 
as well as CHE. However, the goodness-of-fit of the model 
was reasonably good based on Hosmer-Lemeshow test 
(p-value=0.3).
Finally, we limited the scope of the study to Addis Ababa 
due to high burden of CVD and the higher concentra-
tion of CVD specialised centers in the city compared with 
other regions in Ethiopia. Still about 20% of our study 
subjects travelled from outside Addis Ababa.
ConClusIon
Seeking prevention and treatment services for CVD 
in Addis Ababa poses substantial financial risk on 
households, affecting the poorest and those who reside 
outside Addis Ababa more. Drug costs constitute about 
half of the outpatient care expenditures. Economic and 
geographical inequalities should also be considered 
when setting priorities for expanding coverage for these 
services. Expanded coverage has to go hand-in-hand with 
implementation of sound prepayment and risk pooling 
arrangements to ensure financial risk protection to the 
most needy.
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